Darbepoetin alfa: a new approach to the treatment of chemotherapy-induced anaemia

Author： Vansteenkiste Johan   Rossi Gregory   Foote MaryAnn  

Publisher： Informa Healthcare

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.3, Iss.3, 2003-06, pp. : 501-508

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Darbepoetin alfa in the treatment of chemotherapy-induced anaemia

By Wauters Isabelle   Vansteenkiste Johan  

Expert Opinion on Biological Therapy, Vol. 9, Iss. 2, 2009-02 ,pp. : 221-230

Informa Healthcare

Access to resources Recommend Favorite

Darbepoetin alfa: a new therapy for the management of anaemia associated with chronic kidney disease

By Lindberg Jill  

Expert Opinion on Biological Therapy, Vol. 2, Iss. 8, 2002-12 ,pp. : 977-984

Informa Healthcare

Access to resources Recommend Favorite

Drotrecogin alfa: a new approach in the treatment of severe sepsis

By Vincent Jean-Louis  

Expert Opinion on Biological Therapy, Vol. 2, Iss. 6, 2002-08 ,pp. : 659-664

Informa Healthcare

Access to resources Recommend Favorite

Darbepoetin alfa in anemia of myelodysplastic syndromes: present and beyond

By Kelaidi C   Fenaux P  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 4, 2010-04 ,pp. : 605-614

Informa Healthcare

Access to resources Recommend Favorite

Albinterferon-alfa 2b: a new treatment option for hepatitis C

By Flisiak Robert   Flisiak Iwona  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 10, 2010-10 ,pp. : 1509-1515

Informa Healthcare

Access to resources Recommend Favorite